Novo Nordisk, AstraZeneca and Lilly will top pharma's revenue growth in 2023: report

Entrenched pharma giants Pfizer, Merck & Co. and Johnson & Johnson may continue to hold the top spots as the biggest drugmakers by sales in 2023. But the list of companies on track to deliver the most growth is expected to look quite different.